Strategic Partnerships Leverage existing distribution agreements with Medtronic, Nihon Kohden, Panakeia and planned collaborations to expand PMD-200 and NOLedge reach into Europe, Japan, US government institutions, and new markets, accelerating adoption.

Institutional Adoption Target critical care and perioperative departments where non-communicating patients require pain assessment, focusing on hospitals and academic centers via Jefferson University collaboration and FDA/authorized channels to drive formal utilization cases.

Executive Leadership Engage the newly appointed Executive Chairman to open strategic networks, influence large healthcare buyers, and accelerate fundraising and partnerships with global medtech players to scale market entry.

Pain Management Trends Capitalize on growth in nociception monitoring as a means to reduce opioid use and improve patient outcomes, aligning with payer and hospital initiatives to improve safety metrics and cost containment.

Global Expansion Prioritize markets with existing distributors and regional demand such as Canada, Latin America, Israel, UAE and Australia, while pursuing regulatory-ready opportunities in Japan and the US through Nihon Kohden and Panakeia partnerships.